| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240076 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 6 Pages |
Abstract
The results of our study have shown that for patients with anal carcinoma who have residual microscopic or very-small-volume disease, a policy of low-dose, reduced-volume, involved-field chemoradiotherapy produces excellent local control and disease-free survival, with low rates of acute and late toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Paul M.D., Ph.D., F.R.C.R., Rachel M.D., M.Sc., F.R.C.R., David M.D., F.R.C.P., F.R.C.R.,